Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models (Q33867634)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models (English)

1 reference

Europe PubMed Central

29 July 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

author name string

Yi-Ping Li

1

1 reference

Europe PubMed Central

29 July 2017

Hye-Na Kang

2

1 reference

Europe PubMed Central

29 July 2017

Lorne-A Babiuk

3

1 reference

Europe PubMed Central

29 July 2017

Qiang Liu

4

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 November 2006

1 reference

Europe PubMed Central

29 July 2017

World Journal of Gastroenterology

1 reference

Europe PubMed Central

29 July 2017

12

1 reference

Europe PubMed Central

29 July 2017

44

1 reference

Europe PubMed Central

29 July 2017

7126-7135

1 reference

Europe PubMed Central

29 July 2017

Cellular immune responses against hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Prospects for a vaccine against the hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Humoral immune response in acute hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

DNA vaccines: progress and challenges

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

T cell response in hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Genetic diversity and evolution of hepatitis C virus--15 years on

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

A candidate DNA vaccine elicits HCV specific humoral and cellular immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Immunogenicity of HIV-1 Env and Gag in baboons using a DNA prime/protein boost regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

IL-23 induces stronger sustained CTL and Th1 immune responses than IL-12 in hepatitis C virus envelope protein 2 DNA immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Optimal Induction of T-Cell Responses against Hepatitis C Virus E2 by Antigen Engineering in DNA Immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

DNA vaccine strategies: candidates for immune modulation and immunization regimens.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Glycosylation of hepatitis C virus envelope proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

DNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBV

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Cellular immune responses against hepatitis C virus: the evidence base 2002

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

DNA vaccines: future strategies and relevance to intracellular pathogens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Nuclear localization of the ORF2 protein encoded by porcine circovirus type 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

DNA vaccines: immunology, application, and optimization*

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Quantification of the number of cytotoxic T cells specific for an immunodominant HCV-specific CTL epitope primed by DNA immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Folding, assembly and subcellular localization of hepatitis C virus glycoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Limited humoral immunity in hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Hepatitis C virus envelope DNA-based immunization elicits humoral and cellular immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Modulation of immune responses to hepatitis C virus envelope E2 protein following injection of plasmid DNA using single or combined delivery routes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

DNA vaccination for the induction of immune responses against hepatitis C virus proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Antigenicity of hepatitis C virus envelope proteins expressed in Chinese hamster ovary cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Functional diversity of helper T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Demonstration of sugar moiety on the surface of hepatitis C virions recovered from the circulation of infected humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

A new technique for the assay of infectivity of human adenovirus 5 DNA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Selection of highly transfectable variant from mouse mastocytoma P815.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

28 July 2018

Global epidemiology of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Structural biology of hepatitis C virus

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Enveloped particles in the serum of chronic hepatitis C patients

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Cell-mediated immunity and the outcome of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Adaptive immune responses in acute and chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Strategies for designing and optimizing new generation vaccines

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Technological advances to increase immunogenicity of DNA vaccines

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Approaches to enhance the efficacy of DNA vaccines

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Immune responses and protection induced by DNA vaccines encoding bovine parainfluenza virus type 3 glycoproteins

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Hypervariable region 1 variant acting as TCR antagonist affects hepatitis C virus-specific CD4+ T cell repertoire by favoring CD95-mediated apoptosis.

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V12.I44.7126

21 January 2018

Course and outcome of hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

29 October 2018

CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

29 October 2018

Characterization of truncated forms of hepatitis C virus glycoproteins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

29 October 2018

Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

29 October 2018

Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4087773

29 October 2018

Porcine genomics delivers new tools and results: this little piggy did more than just go to market

1 reference

https://pubmed.ncbi.nlm.nih.gov/17131474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/17131474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A specific antibody response to HCV E2 elicited in mice by intramuscular inoculation of plasmid DNA containing coding sequences for E2

1 reference

https://pubmed.ncbi.nlm.nih.gov/17131474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

1 reference

https://pubmed.ncbi.nlm.nih.gov/17131474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compatibility of plasmids expressing different antigens in a single DNA vaccine formulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17131474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3748/WJG.V12.I44.7126

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33867634&oldid=1533253994"